1350 related articles for article (PubMed ID: 28533404)
1. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
2. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.
Lambert MR; Spinazzola JM; Widrick JJ; Pakula A; Conner JR; Chin JE; Owens JM; Kunkel LM
Mol Ther; 2021 Mar; 29(3):1086-1101. PubMed ID: 33221436
[TBL] [Abstract][Full Text] [Related]
3. Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.
Vieira NM; Elvers I; Alexander MS; Moreira YB; Eran A; Gomes JP; Marshall JL; Karlsson EK; Verjovski-Almeida S; Lindblad-Toh K; Kunkel LM; Zatz M
Cell; 2015 Nov; 163(5):1204-1213. PubMed ID: 26582133
[TBL] [Abstract][Full Text] [Related]
4. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.
Li M; Andersson-Lendahl M; Sejersen T; Arner A
FASEB J; 2014 Apr; 28(4):1593-9. PubMed ID: 24371125
[TBL] [Abstract][Full Text] [Related]
5. The golden retriever model of Duchenne muscular dystrophy.
Kornegay JN
Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
[TBL] [Abstract][Full Text] [Related]
6. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
[TBL] [Abstract][Full Text] [Related]
8. X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.
Barthélémy I; Calmels N; Weiss RB; Tiret L; Vulin A; Wein N; Peccate C; Drougard C; Beroud C; Deburgrave N; Thibaud JL; Escriou C; Punzón I; Garcia L; Kaplan JC; Flanigan KM; Leturcq F; Blot S
Skelet Muscle; 2020 Aug; 10(1):23. PubMed ID: 32767978
[TBL] [Abstract][Full Text] [Related]
9. Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy.
Nghiem PP; Bello L; Stoughton WB; López SM; Vidal AH; Hernandez BV; Hulbert KN; Gourley TR; Bettis AK; Balog-Alvarez CJ; Heath-Barnett H; Kornegay JN
Yale J Biol Med; 2017 Sep; 90(3):351-360. PubMed ID: 28955176
[TBL] [Abstract][Full Text] [Related]
10. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
11. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
[TBL] [Abstract][Full Text] [Related]
12. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
14. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
[TBL] [Abstract][Full Text] [Related]
15. A normal life without muscle dystrophin.
Zatz M; Vieira NM; Zucconi E; Pelatti M; Gomes J; Vainzof M; Martins-Bach AB; Garcia Otaduy MC; Bento dos Santos G; Amaro E; Landini V; Andrade T
Neuromuscul Disord; 2015 May; 25(5):371-4. PubMed ID: 25770920
[TBL] [Abstract][Full Text] [Related]
16. Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.
Echigoya Y; Nakamura A; Nagata T; Urasawa N; Lim KRQ; Trieu N; Panesar D; Kuraoka M; Moulton HM; Saito T; Aoki Y; Iversen P; Sazani P; Kole R; Maruyama R; Partridge T; Takeda S; Yokota T
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4213-4218. PubMed ID: 28373570
[TBL] [Abstract][Full Text] [Related]
17. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
[TBL] [Abstract][Full Text] [Related]
18. GRMD cardiac and skeletal muscle metabolism gene profiles are distinct.
Markham LW; Brinkmeyer-Langford CL; Soslow JH; Gupte M; Sawyer DB; Kornegay JN; Galindo CL
BMC Med Genomics; 2017 Apr; 10(1):21. PubMed ID: 28390424
[TBL] [Abstract][Full Text] [Related]
19. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M
Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
Martin PT; Golden B; Okerblom J; Camboni M; Chandrasekharan K; Xu R; Varki A; Flanigan KM; Kornegay JN
PLoS One; 2014; 9(2):e88226. PubMed ID: 24505439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
